发明申请
US20090105304A1 COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS 有权
使用CANNABINOID受体配体减少副作用的联合治疗

  • 专利标题: COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS
  • 专利标题(中): 使用CANNABINOID受体配体减少副作用的联合治疗
  • 申请号: US12252811
    申请日: 2008-10-16
  • 公开(公告)号: US20090105304A1
    公开(公告)日: 2009-04-23
  • 发明人: William A. Carroll
  • 申请人: William A. Carroll
  • 申请人地址: US IL Abbott Park
  • 专利权人: ABBOTT LABORATORIES
  • 当前专利权人: ABBOTT LABORATORIES
  • 当前专利权人地址: US IL Abbott Park
  • 主分类号: A61K31/454
  • IPC分类号: A61K31/454 A61K31/44 A61P25/28
COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS
摘要:
The present application describes a method of treating conditions treatable with a CB2 cannabinoid receptor agonist with reduced CB1-mediated side effects using a combination therapy comprising a CB2 agonist and a CB1 ligand, which can be a CB1 antagonist or a CB1 inverse agonist.
信息查询
0/0